课题基金 / 基金详情

Development of novel heat-induced cytokine gene therapy against malignant gliomas

Development of novel heat-induced cytokine gene therapy against malignant gliomas
针对恶性胶质瘤的新型热诱导细胞因子基因疗法的开发
批准号:
12470286
负责人:
TANAKA Ryuichi
金额:
$2.82万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002

项目摘要

项目成果

TANAKA Ryuichi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1) First, we constructed LacZ gene expression vector under the control of heat shock protein 70 (hsp70) promoter (hsp70/LacZ). Then three human glioma cell lines (U251-MG, T98G, NP2) and one mouse glioma cell line (203) were transfected with hsp70/LacZ vector using lipofection method. After selection with G418, the stable transfectants were obtained. Using these transfectants, the expression of beta-galactosidase after heating was measured. The condition of heating was 41℃ for 2h, 42℃ for 1h, or 43℃ for 1h. The results showed that the peak of the beta-galactosidase expression was between 3h and 24h after heating, even though the degree of its expression varied among the cell lines. (In contrast to other cell lines, the expression was positive in U251-MG cells even with 37℃ heating as a negative control.)2) As a next step, we constructed CD40 ligand (CD40L) gene expression vector under the control of hsp70 promoter (hsp70/CD40L). Then we transfected the vector into mouse 203 glioma cell … More or human NP2 glioma cell by lipofection method. After the selection with G418, we obtained stable transfectants, hsp70/CD40L-203 or hsp70/CD40L-NP2. Using each transfectants, we measured the expression of CD40L protein in the supernatant of the culture medium after heating using ELISA. The results revealed that the peak expression of CD40L protein was between 3h and 48h after heating.3) Furthermore, we constructed IFN-gamma gene expression vector under the control of hsp70 (hsp70/IFN-gamma). The stable transfectant with this vector (hsp70/IFN-gamma-203) was established after the selection with G418. Using this transfectant, we measured the expression of IFN-gamma protein in the supernatant of the culture medium after heating at 42℃ for 1h using ELISA. The result showed that the expression peaked at 24h after the heating. There was no expression of IFN-gamma observed with the treatment of 37℃ heating as a negative control.4) Taken together, in most of the glioma cell lines except for U251-MG cells, the peak expression of the inserted gene by heating was observed between 3h and 48h after heating, even though the expression pattern varied depending on each cell line. Therefore, this gene expression system using hsp70 promoter can be a good candidate for heat-inducible gene treatments. Less
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
H.Takahashi: "Successful Treatments of Malignant Glioma in the Elderly by Radiofrequency Interstitial Hyperthermia : A Report of Two Cases"Jpn J Hyperthermic Oncol. 18・3. 157-164 (2002)
H. Takahashi:“射频间质热疗成功治疗老年人恶性神经胶质瘤:两个病例的报告”Jpn J Hyperthermic Oncol 18・3(2002)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
田中 隆一: "VIII.温熱療法悪性グリオーマの温熱療法"In : 脳神経外科Advanced Practice 5、神経膠腫. 136-141 (2002)
Ryuichi Tanaka:“VIII. 恶性神经胶质瘤的热疗”,见:神经外科高级实践 5,神经胶质瘤 136-141 (2002)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
田中 隆一: "第7章 温熱療法 最近の進歩"In : 先端医療シリーズ18、脳腫瘍の最新医療. 227-231 (2003)
Ryuichi Tanaka:“第 7 章热疗的最新进展”,载于:高级医学系列 18,脑肿瘤的最新医学治疗 (2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
田中 隆一: "脳腫瘍の温熱療法 : 悪性グリオーマのRF組織内加温法"In : 集学的癌治療の研究と臨床,監修. 305-313 (2002)
Ryuichi Tanaka:“脑肿瘤的热疗:恶性神经胶质瘤的射频组织加温方法”,载于:多学科癌症治疗的研究和临床实践,监督305-313(2002)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
7
    On the Relationship between Human Resource Allocation and Macroeconomic Productivity : An Educational Economic Approach
    Trial of novel thermo-gene therapy for malignant brain tumors-Aiming for enhancement of hyperthermia using p53 introduction-
    • 批准号:
      15390430
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.02万
    • 财政年份:
      2003
    • 负责人:
      TANAKA Ryuichi
    • 依托单位:
    Investigation of noninvasive heating system using re-entrant type applicator for malignant brain tumor
    • 批准号:
      13557115
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $3.07万
    • 财政年份:
      2001
    • 负责人:
      TANAKA Ryuichi
    • 依托单位:
    A new chemothermotherapy focusing to the tumor invading zone of malignant glioma by thermosensitive liposome
    • 批准号:
      09557115
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $4.67万
    • 财政年份:
      1997
    • 负责人:
      TANAKA Ryuichi
    • 依托单位:
    海外基金